Imunon, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures
Imunon, Inc. (IMNN) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures of 6.34 thousand shares for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures · last filed 2022-03-31
- Imunon, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2020-12-31 was -88.72K shares.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2020 was 6.34K shares.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2018 was 1.64M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 12 month as first filed |
|---|---|---|---|---|
| 2020-12-31 | -88.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 6.34K shares 10-K · filed 2022-03-31 | 95.06K shares 10-K · filed 2021-03-19 | |
| 2020-09-30 | 95.06K shares 10-Q · filed 2020-11-16 | |||
| 2018-12-31 | 1.64M shares 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |